Nidan Laboratories Cites SEBI Exemption on Corporate Governance Compliance
Nidan Laboratoris & Healthcare Pvt Ltd 路 Others (Uncategorized) 路 05 Oct 2026, 9:28 pm
Nidan Laboratories Cites SEBI Exemption on Corporate Governance Compliance Nidan Laboratories and Healthcare Limited notified the NSE regarding the non-applicability of Corporate Governance reporting under Regulation 27 of SEBI (LODR) Regulations, 2015, for the quarter ended 30th Sep'26. The company stated it is exempted under Regulation 15 of SEBI (LODR) due to its listing on the NSE SME platform, relieving it from filing quarterly corporate governance compliance reports.
Original exchange filing (PDF)
More announcements from Nidan Laboratoris & Healthcare Pvt Ltd
- Nidan Laboratories And Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- NIDAN LABORATORIES AND HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 05 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 05 Nov 2026
- Nidan Laboratories And Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 28, 2026. Further, the company has informed the Exchange regarding voting results. 路 29 Sept 2026
- Nidan Laboratories And Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2026 路 28 Sept 2026
- Nidan Laboratories And Healthcare Limited has informed the Exchange regarding Notice of undefined to be held on September 28, 2026 路 02 Sept 2026
- Nidan Laboratories And Healthcare Limited has informed the Exchange regarding 'Book Closure'. 路 20 Aug 2026
- Nidan Laboratories And Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 20, 2026. 路 20 Aug 2026
